|
|
CP3 is now on LinkedIn! Follow our new page to stay up to date on our latest research, grants, media coverage, and team highlights.
|
|
|
|
|
|
Our latest Visiting Scholar, Adam Bress, PharmD, MS (pictured below), spent time on the Pitt campus May 10-13 in a visit co-sponsored by the Pitt School of Pharmacy. Dr. Bress is a Professor of Population Health Sciences at the University of Utah School of Medicine. Dr. Bress delivered two seminars: “Intensive Blood Pressure Control: What We Have Learned, What Comes Next, and What Longitudinal Plasma Biomarkers in SPRINT Might Tell Us About Interactions with Alzheimer’s Pathology and Dementia Risk” and “From Idea to Award: Strategies for Successful Grantwriting.” He also delivered a research talk as part of VA Pittsburgh's Research Week and met with Health Sciences faculty and students to discuss shared interests. We look forward to future collaborations with Dr. Bress!
|
|
|
|
Dr. Juan Hincapie-Castillo, visiting associate professor in the Department of Pharmacy and Therapeutics, has been named a Fellow of the International Society for Pharmacoepidemiology (ISPE). The ISPE Board of Directors established the membership category of ISPE Fellow to recognize and advance leadership in the Society. He will be recognized at the upcoming 2026 ISPE Annual Meeting in Milan, Italy. Congratulations!
|
|
|
|
|
|
We are pleased to announce that the Developing and Evaluating a Machine-Learning Buprenorphine Care Discontinuity Prediction E-Tool (BUP-CARE) project has been funded by the National Institute on Drug Abuse (NIDA), with CP3’s Dr. Jenny Lo-Ciganic serving as Principal Investigator at Pitt. Buprenorphine is an evidence-based treatment for opioid use disorder (OUD) that reduces overdose and mortality risk, yet more than half of patients discontinue therapy within six months of starting. BUP-CARE will develop and evaluate machine-learning algorithms and prototype a clinical decision support tool to alert primary care providers when patients are at high risk of discontinuing buprenorphine.
|
|
|
|
Drs. Walid Gellad and Courtney Kuza were pleased to represent CP3 at the College on Problems of Drug Dependence (CPDD) Annual Scientific Conference in Portland, OR. Both took part in a mini-symposium, “Machine-Learning Approaches to Overdose Risk Prediction: Implementation Challenges and Lessons Learned,” alongside colleagues Dr. Brandon Marshall and Alexandra Skinner, MPH, of Brown Public Health. Their talk, “Implementing a Machine Learning–Driven Nudge Intervention for Opioid Safety in Primary Care: Lessons from mPROVEN,” shared lessons learned from deploying a machine learning model in the electronic health record.
|
|
|
|
A STAT article highlights major shifts in CVD prevention guidelines, including considering statins as early as age 30 and using updated risk tools. CP3’s Dr. Tim Anderson, interviewed for the article, notes the focus on balancing long-term benefits with risks and identifying high-risk patients earlier.
The University of Minnesota’s Center for Infectious Disease Research and Policy (CIDRAP) examined strategies to curb inappropriate antibiotic prescribing in dental care, a persistent driver of antimicrobial resistance and patient harm. CP3’s Dr. Katie Suda was interviewed, sharing insights on prescribing trends and stressing the need for clearer guidelines, clinician education, and system-level supports.
|
|
|
|
CP3 always has a good showing at the ISPOR (The Professional Society for Health Economics and Outcomes Research) annual conference, and this year was no exception. Not only did our machine learning expert Dr. Jenny Lo-Ciganic present as part of a panel on advanced AI methods (below, left), but she was also interviewed by ACCP Journals Podcast about her machine learning work to predict falls among older adults with depression. You can listen to the episode here.
Next, CP3 doctoral student Yilei Liu presented a poster on her research with Dr. Katie Suda (below, middle).
Finally, former CP3 Associate Director, Dr. Inma Hernandez delivered the plenary lecture, discussing US pharmaceutical policy (below, right).
|
|
|
|
Stay tuned! This October, CP3 will present on multiple research projects at the Addiction Health Services Research (AHSR) conference.
|
|
|
|
Selected Recently Published Papers
|
|
Comparison of Cardiovascular Disease Risk Estimates Using Enhanced PREVENT Equations
Linnea M. Wilson, MPH, Jeremy B. Sussman, MD, MS, Margaret F. Zupa, MD, MS, Timothy S. Anderson, MD, MAS
American Journal of Preventive Medicine, June 12, 2026
Supply Chain Events and Risk of Drug Shortage in Canada
Araniy Santhireswaran, BS; Martin K. H. Ho, PharmD; Katherine Callaway Kim, MPH, PhD; Shanzeh Chaudhry, MSc; Katie J. Suda, PharmD, MS; Etienne Gaudette, PhD; Lisa Burry, PharmD, PhD; Mina Tadrous, PharmD, PhD
JAMA Network Open, June 4, 2026
Improving machine learning prediction of hepatitis C virus infection by incorporating social determinants of health from clinical notes via natural language processing and contextual-level data
Jungjun Bae, Suk-Chan Jang, Pilar Hernandez-Con, Chanakan Jenjai, Ashley Stultz, Shunhua Yan, Daniel Paredes Pardo, Yonghui Wu, Wei-Hsuan Lo-Ciganic, Khoa Nguyen, Faheem Guirgis, Christine Gage, Robert Cook, Ramzi Salloum, David R. Nelson, Haesuk Park
Journal of Hepatology, May 2026
Distribution of Gastrointestinal and Dietary Risk Factors Among U.S. Adults Classified as Having Iron Deficiency Anemia Across Diagnostic Thresholds
Omar Al Ta'ani, Bridget M Mayrer, Nicole M Luche, Shazia Mehmood Siddique, Scott A Peslak, Timothy S Anderson, Ravy K Vajravelu
Hematology, May 30, 2026
Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages
Katie J. Suda, Xinhua Zhao, Sherrie L. Aspinall, Yaming Li, Katherine Callaway Kim, Francesca E. Cunningham, Taylor L. Boyer, Tate W. Miner, Clara Kima, Walid F. Gellad, Peter A. Glassman, Chester B. Good, Felicia Skelton, Mina Tadrous, Carolyn T. Thorpe
Pharmacoepidemiology & Drug Safety, May 19, 2026
Opioid Prescribing by US Dentists and Dental Specialists after Continuing Education
D E Polk, A Carrasco-Labra, N H Shah, N Mukhopadhyay, K J Suda
JDR Clinical and Translational Research, May 6, 2026
Initiation of Medications for Alcohol Use Disorder Among Hospitalized Veterans:A Retrospective Cohort Study
Timothy S. Anderson, MD, MAS, Soumik Purkayastha, PhD, Eden Y. Bernstein, MD, MPH, Alyssa Parr, MPA, Maria K. Mor, PhD, Rachel L. Bachrach, Walid F. Gellad, MD, MPH, Leslie R.M. Hausmann, PhD, Michael J. Fine, MD, MSc, and Utibe R. Essien, MD, MPH
Annals of Internal Medicine, May 5, 2026
Machine Learning Prediction and Reducing Overdoses With Electronic Health Record Nudges (mPROVEN) in the Primary Care Setting: Protocol for a Cluster Randomized Controlled Trial
Walid F Gellad; Yi-Fan Chen; Tae Woo Park; Qingnan Yang; Jonathan D Arnold; Courtney C Kuza; Stephanie N Fedro-Byrom; Julie Diiulio; Laura G Militello; Michelle Whitlock; Eugene M Sadhu; Shyam Visweswaran; Michael J Fine; Kaleab Z Abebe; Katie J Suda; Wei-Hsuan Lo-Ciganic
JMIR Research Protocols, May 4, 2026
Trends and geographic disparities in maintenance dose of buprenorphine for opioid use disorder: A cross-sectional pharmacy claims analysis
Roisin M Sabol, Bridget M Mayrer, Timothy S Anderson, Bryant Shuey, Payel Roy, Katie J Suda, Tae Woo Park
Journal of Substance Use and Addiction Treatment, April 28, 2026
Heavy Drinking, Alcohol Use Disorder, and Obesity
Bryant Shuey, Timothy S Anderson, James Franklin Wharam, Jane M Liebschutz, Jing Luo, Katie J Suda, Eden Y Bernstein
JAMA Internal Medicine, April 20, 2026
|
|
|
|
